Quantum redactiones paginae "Inhibitor receptorii angiotensini II" differant
Content deleted Content added
mNo edit summary |
|||
Linea 1:
[[Fasciculus:Renin-angiotensin-aldosterone system.png|thumb|500px|Inhibitores receptorii angiotensini II ad [[Systema renini-angiotensini-aldosteroni|systematem renini-angiotensini-aldosteroni]] (SRAA) efficacem sunt.]]
'''Inhibitores receptorii angiotensini II''' vel '''antagonistae receptori AT<sub>1</sub>''' vel brevius '''sartani''' sunt grex [[medicamentum pharmaceuticum|medicamentorum]] cum effectibus praecipue [[hypertensio|antihypertensivis]], qui ad [[Systema renini-angiotensini-aldosteroni|systematem renini-angiotensini-aldosteroni]] (SRAA) efficacem sunt<ref>{{cite journal |authors=Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S |title=Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology |journal=Clin Sci |volume=112 |year=2007 |month=apr |pages=417-28 |url=http://www.clinsci.org/content/112/8/417 }}</ref>. Cunctorum inhibitorum receptorii angiotensini II [[Systema classificationis Anatomicum Therapeuticum Chemicumque|Codex ATC]] est [[Codex ATC C09CA|C09CA]].
Effectibus similes sunt [[Inhibitor enzymi angiotensinum convertentis|inhibitores enzymi angiotensinum convertentes]], qui non angiotensini II receptoria obsident sed enzymum angiotensinum II formantem. Verbis aliis: Inhibitores enzymi angiotensinum convertentes ''prae'' angiotensinum II, verum hi inhibitores receptorii angiotensini II ''post'' angiotensinum II agunt.
== Substantia singulares ==
| |||